Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.41 |
| ▸ | CA1 known ✓ | P00915 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | MGAM | O43451 | 3/20 | 0.41 |
| ▸ | PRKCA | P17252 | 3/20 | 0.41 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.41 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.41 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.41 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Potassium Ion SCHEMBL725645 | 0.97 | LMNA (0.42) | RECQLMAPK1BLMGLAHPGD | |
| SCHEMBL10496151 | 0.89 | RECQL (0.52) | RECQLMAPK1BLMGLAHPGD | |
| SCHEMBL4641831 | 0.89 | RECQL (0.52) | RECQLMAPK1BLMGLAHPGD | |
| SCHEMBL5154873 | 0.89 | RECQL (0.52) | RECQLMAPK1BLMGLAHPGD | |
| SCHEMBL10439386 | 0.89 | RECQL (0.52) | RECQLMAPK1BLMGLAHPGD | |
| SCHEMBL17336087 | 0.89 | RECQL (0.52) | RECQLMAPK1BLMGLAHPGD | |
| SCHEMBL15797034 | 0.89 | RECQL (0.52) | RECQLMAPK1BLMGLAHPGD | |
| SCHEMBL17336063 | 0.89 | RECQL (0.52) | RECQLMAPK1BLMGLAHPGD | |
| SCHEMBL5157776 | 0.89 | RECQL (0.52) | RECQLMAPK1BLMGLAHPGD | |
| SCHEMBL11418237 | 0.89 | RECQL (0.52) | RECQLMAPK1BLMGLAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2575807-B1 | FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME | NOVAK MAJA (HR) | 2014-02-19 | — | — | EP | claimed |
| EP-2575807-A1 | FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME | Novak, Maja (HR) | 2013-04-10 | — | — | EP | claimed |
| WO-2011148203-A1 | FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME | NOVAK MAJA (HR) | 2011-12-01 | — | — | WO | claimed |
| WO-2010097643-A1 | FORMULATION BASED ON MICRONIZED ZEOLITE, GREEN TEA EXTRACT, AND GENISTEIN AS A THERAPEUTIC AGENT FOR REDUCTION OF BODY WEIGHT AND CELLULITE | NOVATECH ISTRAZIVANJE D.O.O. (HR) | 2010-09-02 | — | — | WO | claimed |
| WO-2010018418-A1 | FORMULATION BASED ON MICRONIZED CLINOPTILOLITE AS THERAPEUTIC AGENT PROVIDING HIGHLY BIOAVAILABLE SILICON | NOVATECH D.O.O. (HR) | 2010-02-18 | — | — | WO | claimed |
| WO-2009133413-A1 | FORMULATION BASED ON MICRONIZED CLINOPTILOLITE AS A THERAPEUTIC AGENT FOR REMOVAL OF TOXINS, BACTERIA AND VIRUSES FROM ORGANISM | NOVATECH D.O.O. (HR) | 2009-11-05 | — | — | WO | claimed |
| EP-3530262-B1 | PERSONAL CARE COMPOSITIONS AND USES | PROCTER & GAMBLE (US) | 2026-01-14 | — | — | EP | disclosed |
| US-11160741-B2 | Personal care compositions and uses | THE PROCTER AND GAMBLE COMPANY (US) | 2021-11-02 | — | — | US | disclosed |
| US-20190262249-A1 | Personal Care Compositions and Uses | THE PROCTER & GAMBLE COMPANY | 2019-08-29 | — | — | US | disclosed |
| EP-3530262-A1 | PERSONAL CARE COMPOSITIONS AND USES | The Procter & Gamble Company (US) | 2019-08-28 | — | — | EP | disclosed |
| WO-2016135521-A1 | DENTAL FORMULATION | BASIC ROBERT (HR) | 2016-09-01 | — | — | WO | disclosed |
| EP-2575807-B1 | FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME | NOVAK MAJA (HR) | 2014-02-19 | — | — | EP | disclosed |
| EP-2575807-A1 | FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME | Novak, Maja (HR) | 2013-04-10 | — | — | EP | disclosed |
| WO-2011148203-A1 | FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME | NOVAK MAJA (HR) | 2011-12-01 | — | — | WO | disclosed |
| WO-2010097643-A1 | FORMULATION BASED ON MICRONIZED ZEOLITE, GREEN TEA EXTRACT, AND GENISTEIN AS A THERAPEUTIC AGENT FOR REDUCTION OF BODY WEIGHT AND CELLULITE | NOVATECH ISTRAZIVANJE D.O.O. (HR) | 2010-09-02 | — | — | WO | disclosed |
| WO-2010018418-A1 | FORMULATION BASED ON MICRONIZED CLINOPTILOLITE AS THERAPEUTIC AGENT PROVIDING HIGHLY BIOAVAILABLE SILICON | NOVATECH D.O.O. (HR) | 2010-02-18 | — | — | WO | disclosed |
| WO-2009133413-A1 | FORMULATION BASED ON MICRONIZED CLINOPTILOLITE AS A THERAPEUTIC AGENT FOR REMOVAL OF TOXINS, BACTERIA AND VIRUSES FROM ORGANISM | NOVATECH D.O.O. (HR) | 2009-11-05 | — | — | WO | disclosed |